OBJECTIVE:To characterize the dying experience of patients with cancer over the last 6 months of life. STUDY DESIGN A retrospective analysis of the last 6 months of life among patients with colon cancer and nonsmall cell lung cancer enrolled in a prospective cohort study from

Immune checkpoint inhibitors (ICIs) are widely used for various malignancies. However, their safety and efficacy in patients with a kidney transplant have not been defined. To delineate this, we conducted a multicenter retrospective study of 69 patients with a kidney transplant receiving ICIs between January 2010 and May 2020. For safety, we assessed the incidence, timing, and risk factors of acute graft rejection. For efficacy, objective response rate and

Background-Breast-conserving surgery combined with axillary lymph node dissection and radiotherapy or mastectomy are definitive treatments for women with early-stage breast cancer. Little is known about breast cancer treatment for women with disabilities.